Publications
Enhancing massed prolonged exposure with cannabidiol to improve posttraumatic stress disorder: Design and methodology of a pilot randomized clinical trial.
Straud, C. L., Roache, J. D., Ginsburg, B. C., Baig. M. R., King, V. L., Barron, S., Blount, T. H., Young-McCaughan, S., & Peterson, A. L.; for the STRONG STAR Consortium (2024). Enhancing massed prolonged exposure with cannabidiol to improve posttraumatic stress disorder: Design and methodology of a pilot randomized clinical trial. Contemporary Clinical Trials Communications, 38, 101270. https://doi.org/10.1016/j.conctc.2024.101270
Shifts in stimulus control over opioid use with increasing periods of recovery
AlTfaili H, Lamb RJ, Ginsburg BC. Shifts in stimulus control over opioid use with increasing periods of recovery. Pharmacol Biochem Behav. 2024 Feb;235:173693. doi: 10.1016/j.pbb.2023.173693. Epub 2023 Dec 15. PMID: 38104948.
Astaxanthin and meclizine extend lifespan in UM-HET3 male mice; fisetin, SG1002 (hydrogen sulfide donor), dimethyl fumarate, mycophenolic acid, and 4-phenylbutyrate do not significantly affect lifespan in either sex at the doses and schedules used
Harrison DE, Strong R, Reifsnyder P, Rosenthal N, Korstanje R, Fernandez E, Flurkey K, Ginsburg BC, Murrell MD, Javors MA, Lopez-Cruzan M, Nelson JF, Willcox BJ, Allsopp R, Watumull DM, Watumull DG, Cortopassi G, Kirkland JL, Tchkonia T, Choi YG, Yousefzadeh MJ, Robbins PD, Mitchell JR, Acar M, Sarnoski EA, Bene MR, Salmon A, Kumar N, Miller RA. Astaxanthin and meclizine extend lifespan in UM-HET3 male mice; fisetin, SG1002 (hydrogen sulfide donor), dimethyl fumarate, mycophenolic acid, and 4-phenylbutyrate do not significantly affect lifespan in either sex at the doses and schedules used. Geroscience. 2024 Feb;46(1):795-816. doi: 10.1007/s11357-023-01011-0. Epub 2023 Dec 2. PMID: 38041783; PMCID: PMC10828146.
Feasibility of a telehealth-based contingency management intervention for alcohol use disorders using the phosphatidylethanol (PEth) 16:0/18:1 alcohol biomarker: a pilot randomized trial
Jett JD, Beck R, Tyutyunnyk D, Sanchez J, Weeks DL, Javors MA, Hill-Kapturczak N, Lopez-Cruzan M, Kriegel L, Ginsburg BC, Cabassa L, McDonell MG. Feasibility of a telehealth-based contingency management intervention for alcohol use disorders using the phosphatidylethanol (PEth) 16:0/18:1 alcohol biomarker: a pilot randomized trial. Am J Drug Alcohol Abuse. 2024 Jan 29:1-11. doi: 10.1080/00952990.2023.2283691. Epub ahead of print. PMID: 38284925.
Effects of an Ethanol-Paired Conditioned Stimulus on Responding for Ethanol Suppressed by a Conditioned-Taste-Aversion
Lamb RJ, Schindler CW, Ginsburg BC. Effects of an Ethanol-Paired Conditioned Stimulus on Responding for Ethanol Suppressed by a Conditioned-Taste-Aversion. Alcohol. 2023 Sep 27:S0741-8329(23)00280-X. doi: 10.1016/j.alcohol.2023.09.008. Epub ahead of print. PMID: 37774959.